JC
Jeffrey Campbell
See Remarks

Jeffrey Campbell insider trades: Alpharma (ALO) stock buys and sales

See Remarks, Alpharma Last trade Jun 13, 2008 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2006
1
Company
last trade 2008

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 13, 2008ALO↑ Buy$70K
Dec 31, 2007ALO↓ Sell$248K
Mar 9, 2007ALO↓ Sell10b5-1$79K
Dec 15, 2006ALO↓ Sell10b5-1$158K
Nov 14, 2006ALO↓ Sell10b5-1$88K
Aug 22, 2006ALO↓ Sell10b5-1$39K
Mar 30, 2006ALO↓ Sell10b5-1$136K
Mar 17, 2006ALO↓ Sell$553K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeffrey Campbell's insider trades

Jeffrey Campbell is See Remarks at Alpharma (ALO). Since Mar 17, 2006, Jeffrey has reported 1 open-market purchase worth $70K and 7 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

5 sales (38% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (8 filings), option exercises (5 filings), shares withheld for taxes (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.